Results 221 to 230 of about 2,197,203 (280)
A method for English paragraph grammar correction based on differential fusion of syntactic features. [PDF]
Liu W +7 more
europepmc +1 more source
ABSTRACT Groups are motivated not only by resources and status, but also by whether they matter to others. We introduce collective anti‐mattering, the belief that one's group does not count in the eyes of outgroups or society, and examine its emotional and political consequences.
Nassim Tabri +2 more
wiley +1 more source
Eye-movement signatures of syntactic development: real-time mapping of passive sentence comprehension in children aged 6-10. [PDF]
Kruchinina OV +4 more
europepmc +1 more source
Abstract Objective This study was undertaken to identify the incidence of respiratory tract infections (RTIs) in a large cohort of adult patients with status epilepticus (SE) and to characterize their associations with clinical features and outcome determinants.
Sebastian Berger +8 more
wiley +1 more source
Correction: Normoyle et al. Synthesis and Characterization of a Novel Concentration-Independent Fluorescent Chloride Indicator, ABP-Dextran, Optimized for Extracellular Chloride Measurement. <i>Biomolecules</i> 2024, <i>14</i>, 77. [PDF]
Normoyle KP, Lillis KP, Staley KJ.
europepmc +1 more source
Abstract Objective The integration of neurotechnology and artificial intelligence (AI) in epilepsy research has led to significant advancements in diagnosis, monitoring, and treatment. However, the impact of these innovations is often diminished by inadequate and inaccurate reporting, limiting their reproducibility and implementation.
Pedro F. Viana +6 more
wiley +1 more source
Correction: Bhattarai et al. Characterisation of a 4A QTL for Metribuzin Resistance in Wheat by Developing Near-Isogenic Lines. <i>Plants</i> 2021, <i>10</i>, 1856. [PDF]
Bhattarai R, Liu H, Siddique KHM, Yan G.
europepmc +1 more source
Early Cessation of Adjuvant Anti‐PD‐1 Therapy in Stage III and IV Melanoma
ABSTRACT One year of adjuvant anti‐PD‐1 has improved disease‐free survival in Stage III melanoma. It is unknown whether shorter treatment duration affects outcomes. Real‐world data may help clarify this. In this retrospective observational study, patients with resected Stage III/IV melanoma receiving adjuvant anti‐PD‐1 in the Netherlands from 2018 to ...
Manja Bloem +20 more
wiley +1 more source

